z-logo
open-access-imgOpen Access
MP35-14 A 17-GENE ASSAY DRIVES HIGH ACTIVE SURVEILLANCE PERSISTENCE IN CLINICALLY LOW-RISK PROSTATE CANCER: 1 YEAR RESULTS FROM A 1,200 PATIENT PROSPECTIVE OBSERVATIONAL TRIAL
Author(s) -
Neal D. Shore,
Gregg Eure,
Daniel R. Saltzstein,
John P. Bennett,
Ruixiao Lu,
Phillip G. Febbo,
Béla Dénes
Publication year - 2018
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2018.02.1127
Subject(s) - medicine , prostate cancer , overdiagnosis , observational study , clinical endpoint , cancer , gynecology , oncology , clinical trial

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom